These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36463277)

  • 21. BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus.
    Argilaguet JM; Pérez-Martín E; López S; Goethe M; Escribano JM; Giesow K; Keil GM; Rodríguez F
    Antiviral Res; 2013 Apr; 98(1):61-5. PubMed ID: 23428670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8
    Darling R; Senapati S; Christiansen J; Liu L; Ramer-Tait AE; Narasimhan B; Wannemuehler M
    Int J Nanomedicine; 2020; 15():6579-6592. PubMed ID: 32982219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an ELISA Method to Differentiate Animals Infected with Wild-Type African Swine Fever Viruses and Attenuated HLJ/18-7GD Vaccine Candidate.
    Wang L; Fu D; Tesfagaber W; Li F; Chen W; Zhu Y; Sun E; Wang W; He X; Guo Y; Bu Z; Zhao D
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.
    Agallou M; Margaroni M; Athanasiou E; Toubanaki DK; Kontonikola K; Karidi K; Kammona O; Kiparissides C; Karagouni E
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005311. PubMed ID: 28114333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinational Deletions of MGF360-9L and MGF505-7R Attenuated Highly Virulent African Swine Fever Virus and Conferred Protection against Homologous Challenge.
    Ding M; Dang W; Liu H; Xu F; Huang H; Sunkang Y; Li T; Pei J; Liu X; Zhang Y; Zheng H
    J Virol; 2022 Jul; 96(14):e0032922. PubMed ID: 35867564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a Nanovaccine Platform Based on an α1,2-Mannobiose Derivative Shows Species-non-specific Targeting to Human, Bovine, Mouse, and Teleost Fish Dendritic Cells.
    Pappalardo JS; Salmaso S; Levchenko TS; Mastrotto F; Bersani S; Langellotti CA; Vermeulen M; Ghersa F; Quattrocchi V; Zamorano PI; Hartner WC; Toniutti M; Musacchio T; Torchilin VP
    Mol Pharm; 2021 Jul; 18(7):2540-2555. PubMed ID: 34106726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.
    Lu Y; Liu ZH; Li YX; Xu HL; Fang WH; He F
    Int J Nanomedicine; 2022; 17():1593-1608. PubMed ID: 35411142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A "trained immunity" inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice.
    Li D; Li W; Zheng P; Yang Y; Liu Q; Hu Y; He J; Long Q; Ma Y
    J Nanobiotechnology; 2023 Mar; 21(1):74. PubMed ID: 36864424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. African Swine Fever Virus F317L Protein Inhibits NF-κB Activation To Evade Host Immune Response and Promote Viral Replication.
    Yang J; Li S; Feng T; Zhang X; Yang F; Cao W; Chen H; Liu H; Zhang K; Zhu Z; Zheng H
    mSphere; 2021 Oct; 6(5):e0065821. PubMed ID: 34668754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcine Immunoglobulin Fc Fused P30/P54 Protein of African Swine Fever Virus Displaying on Surface of S. cerevisiae Elicit Strong Antibody Production in Swine.
    Chen C; Hua D; Shi J; Tan Z; Zhu M; Tan K; Zhang L; Huang J
    Virol Sin; 2021 Apr; 36(2):207-219. PubMed ID: 32915442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.
    Liu J; Liu X; Han Y; Zhang J; Liu D; Ma G; Li C; Liu L; Kong D
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):30983-30993. PubMed ID: 30136844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a viral DNA-protein immunization strategy against African swine fever in domestic pigs.
    Pérez-Núñez D; Sunwoo SY; Sánchez EG; Haley N; García-Belmonte R; Nogal M; Morozov I; Madden D; Gaudreault NN; Mur L; Shivanna V; Richt JA; Revilla Y
    Vet Immunol Immunopathol; 2019 Feb; 208():34-43. PubMed ID: 30712790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The recombinant pseudorabies virus expressing African swine fever virus CD2v protein is safe and effective in mice.
    Feng Z; Chen J; Liang W; Chen W; Li Z; Chen Q; Cai S
    Virol J; 2020 Nov; 17(1):180. PubMed ID: 33198749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of Robust Immune Responses in Swine by Using a Cocktail of Adenovirus-Vectored African Swine Fever Virus Antigens.
    Lokhandwala S; Waghela SD; Bray J; Martin CL; Sangewar N; Charendoff C; Shetti R; Ashley C; Chen CH; Berghman LR; Mwangi D; Dominowski PJ; Foss DL; Rai S; Vora S; Gabbert L; Burrage TG; Brake D; Neilan J; Mwangi W
    Clin Vaccine Immunol; 2016 Nov; 23(11):888-900. PubMed ID: 27628166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
    Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
    ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)-Peptide Tetramers.
    Sun W; Zhang H; Fan W; He L; Chen T; Zhou X; Qi Y; Sun L; Hu R; Luo T; Liu W; Li J
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.